Longevity
Search documents
EUDA Health to Launch EUDA Helixé 2.0 in January 2026
Globenewswire· 2025-12-29 12:00
Core Insights - EUDA Health Holdings Limited is set to launch EUDA Helixé 2.0 in January 2026, representing a significant upgrade in its premium vitality and longevity supplement line [1][6] Product Enhancements - The new formulation includes a 20% increase in New Zealand sourced deer placenta powder, raising the dosage from 100 mg to 120 mg, enhancing its potency [2] - L-glutathione has been replaced with D-alpha-tocopherol (Vitamin E, 1.4 mg equivalent) to improve antioxidant stability and support skin health [2] - Advanced encapsulation technology has been implemented to enhance stability, absorption efficiency, and shelf life, utilizing a nano-based delivery system for smaller capsule sizes [3][8] Packaging and Design - A new proprietary bottle design has been introduced to reflect the premium positioning of EUDA Helixé, enhancing product protection and brand identity [4] Market Expansion - EUDA Helixé 2.0 has received New Zealand Halal certification, facilitating broader international distribution and entry into Muslim markets across Southeast Asia and the Middle East [5] Strategic Positioning - The launch of EUDA Helixé 2.0 underscores the company's commitment to innovation and global wellness solutions, positioning it as a core offering within EUDA's health and longevity ecosystem [6][7] - The company aims to address the healthcare needs of over 1.8 billion people in Asia, focusing on the growing longevity sector as populations age [9]
EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen
Globenewswire· 2025-12-23 12:00
Core Insights - EUDA Health Holdings Limited is accelerating its longevity and regenerative medicine strategy by launching a comprehensive stem cell therapy platform and establishing its first clinic in Shenzhen, China [1][4] Group 1: Strategic Developments - The company has acquired distribution rights for T-cell immunotherapies from Shenzhen Inno Immune Co. Ltd., which specializes in autologous cellular therapeutics [2] - EUDA intends to acquire GO POSB Organoids Pte Ltd., a biotechnology company based in Singapore [2] Group 2: Facility and Technology Enhancements - EUDA is upgrading Shenzhen Inno's cGMP facility to create a state-of-the-art production and innovation center for stem cell treatments, incorporating GO POSB's iPSC technology and advanced stem cell technologies from Japanese partners [3] - The upgraded facility will support iPSC expansion, stem cell preparation, immune cell therapies, and the development of new treatments focused on immune health, skin health, and healthy aging [3] Group 3: Clinic Establishment and Services - A new longevity clinic has been established in Shenzhen in partnership with KB International Ltd., which will introduce Japanese longevity healthcare technologies [4] - The clinic will offer services aimed at enhancing longevity, slowing biological aging, strengthening immunity, and providing long-term health planning [4] Group 4: Company Vision and Market Position - The company aims to become a market leader in non-invasive and preventive healthcare, focusing on the fast-growing longevity sector to address the healthcare needs of over 1.8 billion people in the region [6] - EUDA is positioned to lead the transformation of regional healthcare from reactive treatment to proactive, longevity-focused care [6]
Celularity Announces Closing of Financing Transactions
Globenewswire· 2025-12-22 21:01
Core Viewpoint - Celularity Inc. has successfully closed a financing transaction, enhancing its financial position and supporting its strategic initiatives in regenerative and cellular medicine [1][4]. Financing Details - Celularity received $10.00 million in gross proceeds from the financing, with the potential for an additional $2.0 million based on specific conditions [2]. - The financing structure includes a senior secured term loan of $7.0 million and secured convertible notes with commitments of up to $5.0 million, convertible at a price of $1.66 per share [3]. - The secured convertible notes are backed by a first-priority lien on proceeds from a qualified financing, and Celularity issued warrants for 3,707,657 shares of Class A Common Stock with an exercise price of $2.00 per share [3]. Strategic Focus - The company aims to leverage its placental-derived platform to address significant unmet medical needs related to healthy aging and performance optimization [4]. - Celularity plans to articulate its corporate strategy in the upcoming year, aligning its scientific capabilities with long-term opportunities in longevity and age-related diseases [5]. Company Overview - Celularity Inc. specializes in developing, manufacturing, and commercializing advanced biomaterial products and cell therapies derived from postpartum placenta, targeting fundamental aging mechanisms [7].
The role of mindset, purpose, and relationships in longevity | Barbara Waxman | TEDxBoston
TEDx Talks· 2025-12-22 15:04
I have a confession to make. When I pick up a newspaper, the first thing I do is flip straight to the obituaries. That's right, the obits.It's not because I'm morbid, and it's not because I've been a gerontologist since the field was in its infancy. It's because obituaries are the true highlight reels of our lives. In just a few paragraphs, you see what truly mattered.The passions, the quirks, the loves lost and gained, the impact, the risks taken or not. They're a masterclass in what it takes to live, not ...
The Republic of Longevity | Nicola Palmarini | TEDxCesena
TEDx Talks· 2025-12-18 16:09
Salus Populi Suprema Lex Exto. Il welfare dei cittadini è la legge suprema. Questa è l'iscrizione che trovate in giro per gli edifici pubblici di tutto il mondo ed è forse la regola principale.La nostra salute è la legge suprema. Per la prima volta su questo pianeta ci sono sei generazioni che vivono insieme. Cinque di queste votano insieme, vanno a bere il caffè insieme, si trovano nei barsi nel 2050 ci saranno 2 miliardi di persone over 60 su questo pianeta.Non era mai successo prima. E questo è un argome ...
Morgan Stanley says these are 4 big market themes investors are focused on right now
Yahoo Finance· 2025-12-16 18:15
Group 1: AI Capital Expenditure and Energy Bottleneck - The AI capital expenditure cycle is a dominant force in markets, but energy supply challenges for data centers could hinder this trend [2][3] - The energy build-out trade is identified as a potential opportunity related to AI, with companies like Bloom Energy and Solaris Energy positioned to benefit [4] Group 2: Longevity - The trend of increasing longevity is creating significant market opportunities, as the population aged 60 and above holds one-third of global buying power [5] - Older demographics are becoming more tech-savvy and are increasing their spending on lifestyle products, which can help mitigate growth pressures from retirements [6] Group 3: Tokenized Finance - Tokenization is seen as a way to modernize financial systems by allowing assets to be digitalized and traded on blockchain, enhancing ownership verification [8] - There is ongoing experimentation in the tokenization space, with asset managers launching digital money funds and exploring private market fund distribution on blockchains [8]
主题会议十大要点-Thematics Conference 10 Key Takeaways
2025-12-16 03:30
Summary of Thematic Research Conference Key Takeaways Industry and Company Focus - **Industry**: Thematic Investing - **Key Companies Mentioned**: Bloom Energy (BE), Solaris Energy (SEI), John Deere Core Themes and Insights 1. **Rising Interest in Thematic Investing**: There is a significant increase in investor interest in thematic investing, with a focus on curated portfolios driven by enduring themes [3][8] 2. **AI and Capital Expenditure Cycle**: AI is driving a major capital expenditure and productivity cycle, with power supply becoming a critical bottleneck in the US and Europe [3][4] 3. **Distributed Power Supply Strategies**: The shift towards distributed energy solutions is gaining momentum, with companies like Bloom Energy positioned to benefit from this trend [4][13] 4. **Multipolar World Dynamics**: The geopolitical landscape is evolving, emphasizing technology leadership and the strategic importance of critical minerals [5][8][16] 5. **Long-Term Investment Trends**: Investors are transitioning from short-term trades to long-term trends, focusing on structural megatrends that drive alpha generation [8][14] 6. **AI Diffusion in Traditional Industries**: AI is expanding into traditional sectors such as agriculture and manufacturing, transforming companies like John Deere into "smart industrials" [9][21] 7. **Longevity as a Market Opportunity**: The aging population presents a significant market opportunity, with the 60+ demographic holding substantial buying power [9][17] 8. **Tokenized Finance**: The trend towards tokenized finance is expected to democratize private markets and enhance transaction efficiency [10][24] 9. **Brain-Computer Interfaces**: This emerging technology is positioned at the intersection of healthcare and AI, with significant market potential [10][20] 10. **Execution Challenges**: Across various themes, execution challenges such as power, labor, and regulatory issues are identified as key constraints that can generate alpha [11] Additional Important Insights - **Bloom Energy's Growth Prospects**: Bloom Energy is optimistic about its growth, particularly in the data center segment, with plans to increase manufacturing capacity by 1 GW by 2027 [13] - **Market Underestimation of Power Supply Challenges**: There is a belief that investors may not fully appreciate the complexities and challenges associated with providing high-quality power to data centers [13] - **AI's Role in Agriculture**: AI is enhancing agricultural productivity, with significant data processing capabilities being utilized to optimize farming practices [21] - **Investment Strategies Evolution**: Thematic investment strategies are evolving from human-driven stock selection to systematic thematic baskets, allowing for scalable alpha opportunities [14][18] This summary encapsulates the key takeaways from the Thematic Research Conference, highlighting the critical themes and insights that are shaping the investment landscape.
X @The Wall Street Journal
The Wall Street Journal· 2025-12-13 06:36
In America, the average man can expect to live 75.8 years. Mick Jagger, the demonic frontman of the Rolling Stones, turns 82 on Dec. 18Solving the mystery of the guitarist’s longevity may be the best hope the rest of us have of aging gracefully.🔗: https://t.co/u3lkVu4Ew7 https://t.co/vdYWMvsQNX ...
Vivir 120 años | Damià Tormo | TEDxValencia
TEDx Talks· 2025-12-12 17:10
[música] Os quería pedir antes que nada un favor a todos. Imaginad en vuestras cabezas la siguiente escena. Va saber que es muy sencilla.Es un día cualquiera. Suena el despertador. Son las 8 de la mañana.Te levantas. ¿Todavía te arrepientes de las últimas cervezas que te tomaste anoche. Pero te pones rápidamente tus mallas, tus zapatillas de correr y sales como cada mañana a correr alrededor, 5 km alrededor de tu casa.Vuelves, te duchas, desayunas y te pones a contestar emails que te han quedado en la bande ...
X @Xeer
Xeer· 2025-12-12 17:02
Industry Trend - The longevity and wellness sector is gaining traction, attracting individuals who have achieved financial independence [1] - Individuals with substantial wealth are increasingly choosing to prioritize wellness over accumulating more wealth and status [1] Individual Case Study - Bryan Johnson has strategically aligned himself with the growing interest in longevity and wellness [1] - Bryan Johnson's question explores the shift in priorities among the wealthy, questioning the pursuit of wealth versus opting out [1]